臺灣學術機構典藏系統 (Taiwan Academic Institutional Repository, TAIR)

	English \| 正體中文 \| 简体中文 \| Total items :0
	Visitors : 51893796 Online Users : 870 Project Commissioned by the Ministry of Education Project Executed by National Taiwan University Library

Scope

Adv. Search

Login

管理

臺灣學術機構典藏系統 (Taiwan Academic Institutional Repository, TAIR)

關於TAIR
	計畫說明

瀏覽
	典藏機構
	作者
	題名
	日期
	統計圖表
	機構即時統計
	學術趨勢

消息
	2019臺灣學術機構典藏研討會
	機構典藏系統RC7版本已發佈

著作權
	出版社及期刊政策查詢
	TAIR著作權會議記錄

相關連結
	機構典藏計畫網站
	ROAR
	OpenDOAR
	SHERPA
	OAIster
	JAIRO
	Ira
	DSPACE
	RWWR
	臺大學術典藏NTU Scholars

"liu c j"的相關文件

回到依作者瀏覽
依題名排序	依日期排序

顯示項目 511-520 / 1268 (共127頁)
<< < 47 48 49 50 51 52 53 54 55 56 > >>
每頁顯示[10|25|50]項目

機構	日期	題名	作者
臺大學術典藏	2021-07-03T03:34:30Z	Host genetic variants and hepatitis b virologic features in HBeAg-negative hepatitis B carriers with long-term biochemical remission	Lin C.-L.; Tseng T.-C.; Su T.-H.; Liu C.-J.; PEI-JER CHEN; Lai M.-Y.; Chen D.-S.; Kao J.-H.
臺大學術典藏	2021-07-03T03:34:30Z	Serum interleukin 6 level correlates with outcomes of acute exacerbation of chronic hepatitis B	Pan C.J.-H.; Wu H.-L.; Kuo S.F.-T.; Kao J.-H.; Tseng T.-C.; Liu C.-H.; PEI-JER CHEN; Liu C.-J.; Chen D.-S.
臺大學術典藏	2021-07-03T03:34:28Z	Interleukin 28B genetic polymorphisms play a minor role in identifying optimal treatment duration in HCV genotype 1 slow responders to pegylated interferon plus ribavirin	Liu C.-H.; Liang C.-C.; Liu C.-J.; Tseng T.-C.; Lin C.-L.; Yang S.-S.; Su T.-H.; Lin J.-W.; Chen J.-H.; PEI-JER CHEN; Chen D.-S.; Kao J.-H.
臺大學術典藏	2021-07-03T03:34:28Z	Determinants of spontaneous surface antigen loss in hepatitis B e antigen-negative patients with a low viral load	Tseng T.-C.; Liu C.-J.; Yang H.-C.; Su T.-H.; Wang C.-C.; Chen C.-L.; Fang-Tzu Kuo S.; Liu C.-H.; PEI-JER CHEN; Chen D.-S.; Kao J.-H.
臺大學術典藏	2021-07-03T03:34:27Z	Interleukin 28B genetic polymorphisms and viral factors help identify HCV genotype-1 patients who benefit from 24-week pegylated interferon plus ribavirin therapy	Liu C.-H.; Liang C.-C.; Liu C.-J.; Tseng T.-C.; Lin C.-L.; Yang S.-S.; Su T.-H.; Hsu S.-J.; Lin J.-W.; Chen J.-H.; PEI-JER CHEN; Chen D.-S.; Kao J.-H.
臺大學術典藏	2021-07-03T03:34:26Z	Differential clinical and virologic impact of hepatitis B virus genotypes B and C on HIV-coinfected patients receiving lamivudine-containing highly active antiretroviral therapy	Sheng W.-H.; Hung C.-C.; Chang S.-Y.; Liu C.-J.; Chen M.-Y.; Hsieh S.-M.; Kao J.-H.; PEI-JER CHEN; Chang S.-C.
臺大學術典藏	2021-07-03T03:34:25Z	Young chronic hepatitis b patients with nucleos(t)ide analogue-induced hepatitis b e antigen seroconversion have a higher risk of HBV reactivation	Tseng T.-C.; Liu C.-J.; Su T.-H.; Yang H.-C.; Wang C.-C.; Chen C.-L.; Kuo S.F.-T.; Liu C.-H.; PEI-JER CHEN; Chen D.-S.; Kao J.-H.
臺大學術典藏	2021-07-03T03:34:24Z	IL-21R gene polymorphisms and serum IL-21 levels predict virological response to interferon-based therapy in Asian chronic hepatitis C patients	Hsu C.-S.; Hsu S.-J.; Liu W.-L.; Chen C.-L.; Liu C.-J.; PEI-JER CHEN; Chen D.-S.; Kao J.-H.
臺大學術典藏	2021-07-03T03:34:24Z	Influences of tobacco and alcohol use on hepatocellular carcinoma survival	Shih W.-L.; Chang H.-C.; Liaw Y.-F.; Lin S.-M.; Lee S.-D.; PEI-JER CHEN; Liu C.-J.; Lin C.-L.; Yu M.-W.
臺大學術典藏	2021-07-03T03:34:22Z	Hepatitis B virus reactivation in patients receiving cancer chemotherapy: Natural history, pathogenesis, and management	Liu C.-J.; PEI-JER CHEN; Chen D.-S.; Kao J.-H.

顯示項目 511-520 / 1268 (共127頁)
<< < 47 48 49 50 51 52 53 54 55 56 > >>
每頁顯示[10|25|50]項目